Umbilicial cord glycosylated hemoglobin in infants of diabetic mothers: Relationships to neonatal hypoglycemia, macrosomia, and cord serum C-peptide

Jay M Sosenko, J. L. Kitzmiller, R. Fluckiger

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Relationships of neonatal glycemia and birthweight to antecedent fetal glycemia and insulinemia have been examined in the offspring of 63 insulin-dependent diabetic and 29 nondiabetic mothers. Glycosylated hemoglobin levels in maternal and cord blood were measured by the thiobarbituric acid (TBA) colorimetric technique to estimate antecedent fetal and maternal glycemia; cord serum C-peptide was assayed to estimate fetal insulinemia. Glycosylated hemoglobin levels were significantly elevated in the diabetic mothers and their offspring as compared with controls (P < 0.001), and maternal and cord blood levels were highly correlated in the diabetic group (r = 0.61, P < 0.001). Cord serum C-peptide and glycosylated hemoglobin levels tended to be associated (r = 0.43, P < 0.10). Hypoglycemic infants of diabetic mothers (IDM) had significantly higher glycosylated hemoglobin levels (A443 nm/10 mg hemoglobin hemolysate) in cord blood (0.173 ± 0.009) than did IDM without hypoglycemia (0.153 ± 0.005, P < 0.01). Macrosomic and nonmacrosomic IDM, on the other hand, did not differ as to their glycosylated hemoglobin levels (0.162 ± 0.005 versus 0.161 ± 0.006, respectively). The occurrence of hypoglycemia was not associated with that of macrosomia (X2 = 0.24, P > 0.10). These data strongly suggest that neonatal hypoglycemia is the result of maternal hyperglycemia in pregnancy and consequent fetal hyperglycemia and hyperinsulinemia. However, maternal hyperglycemia in late pregnancy may not be a sufficient explanation for the development of macrosomia in IDM.

Original languageEnglish
Pages (from-to)566-570
Number of pages5
JournalDiabetes Care
Volume5
Issue number6
StatePublished - Dec 1 1982

Fingerprint

C-Peptide
Glycosylated Hemoglobin A
Hypoglycemia
Mothers
Serum
Hyperglycemia
Pregnancy
Hyperinsulinism
Fetal Blood
Insulin

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Umbilicial cord glycosylated hemoglobin in infants of diabetic mothers : Relationships to neonatal hypoglycemia, macrosomia, and cord serum C-peptide. / Sosenko, Jay M; Kitzmiller, J. L.; Fluckiger, R.

In: Diabetes Care, Vol. 5, No. 6, 01.12.1982, p. 566-570.

Research output: Contribution to journalArticle

@article{02e2f2935ea448e1b585a0bfb30a9f82,
title = "Umbilicial cord glycosylated hemoglobin in infants of diabetic mothers: Relationships to neonatal hypoglycemia, macrosomia, and cord serum C-peptide",
abstract = "Relationships of neonatal glycemia and birthweight to antecedent fetal glycemia and insulinemia have been examined in the offspring of 63 insulin-dependent diabetic and 29 nondiabetic mothers. Glycosylated hemoglobin levels in maternal and cord blood were measured by the thiobarbituric acid (TBA) colorimetric technique to estimate antecedent fetal and maternal glycemia; cord serum C-peptide was assayed to estimate fetal insulinemia. Glycosylated hemoglobin levels were significantly elevated in the diabetic mothers and their offspring as compared with controls (P < 0.001), and maternal and cord blood levels were highly correlated in the diabetic group (r = 0.61, P < 0.001). Cord serum C-peptide and glycosylated hemoglobin levels tended to be associated (r = 0.43, P < 0.10). Hypoglycemic infants of diabetic mothers (IDM) had significantly higher glycosylated hemoglobin levels (A443 nm/10 mg hemoglobin hemolysate) in cord blood (0.173 ± 0.009) than did IDM without hypoglycemia (0.153 ± 0.005, P < 0.01). Macrosomic and nonmacrosomic IDM, on the other hand, did not differ as to their glycosylated hemoglobin levels (0.162 ± 0.005 versus 0.161 ± 0.006, respectively). The occurrence of hypoglycemia was not associated with that of macrosomia (X2 = 0.24, P > 0.10). These data strongly suggest that neonatal hypoglycemia is the result of maternal hyperglycemia in pregnancy and consequent fetal hyperglycemia and hyperinsulinemia. However, maternal hyperglycemia in late pregnancy may not be a sufficient explanation for the development of macrosomia in IDM.",
author = "Sosenko, {Jay M} and Kitzmiller, {J. L.} and R. Fluckiger",
year = "1982",
month = "12",
day = "1",
language = "English",
volume = "5",
pages = "566--570",
journal = "Diabetes Care",
issn = "1935-5548",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - Umbilicial cord glycosylated hemoglobin in infants of diabetic mothers

T2 - Relationships to neonatal hypoglycemia, macrosomia, and cord serum C-peptide

AU - Sosenko, Jay M

AU - Kitzmiller, J. L.

AU - Fluckiger, R.

PY - 1982/12/1

Y1 - 1982/12/1

N2 - Relationships of neonatal glycemia and birthweight to antecedent fetal glycemia and insulinemia have been examined in the offspring of 63 insulin-dependent diabetic and 29 nondiabetic mothers. Glycosylated hemoglobin levels in maternal and cord blood were measured by the thiobarbituric acid (TBA) colorimetric technique to estimate antecedent fetal and maternal glycemia; cord serum C-peptide was assayed to estimate fetal insulinemia. Glycosylated hemoglobin levels were significantly elevated in the diabetic mothers and their offspring as compared with controls (P < 0.001), and maternal and cord blood levels were highly correlated in the diabetic group (r = 0.61, P < 0.001). Cord serum C-peptide and glycosylated hemoglobin levels tended to be associated (r = 0.43, P < 0.10). Hypoglycemic infants of diabetic mothers (IDM) had significantly higher glycosylated hemoglobin levels (A443 nm/10 mg hemoglobin hemolysate) in cord blood (0.173 ± 0.009) than did IDM without hypoglycemia (0.153 ± 0.005, P < 0.01). Macrosomic and nonmacrosomic IDM, on the other hand, did not differ as to their glycosylated hemoglobin levels (0.162 ± 0.005 versus 0.161 ± 0.006, respectively). The occurrence of hypoglycemia was not associated with that of macrosomia (X2 = 0.24, P > 0.10). These data strongly suggest that neonatal hypoglycemia is the result of maternal hyperglycemia in pregnancy and consequent fetal hyperglycemia and hyperinsulinemia. However, maternal hyperglycemia in late pregnancy may not be a sufficient explanation for the development of macrosomia in IDM.

AB - Relationships of neonatal glycemia and birthweight to antecedent fetal glycemia and insulinemia have been examined in the offspring of 63 insulin-dependent diabetic and 29 nondiabetic mothers. Glycosylated hemoglobin levels in maternal and cord blood were measured by the thiobarbituric acid (TBA) colorimetric technique to estimate antecedent fetal and maternal glycemia; cord serum C-peptide was assayed to estimate fetal insulinemia. Glycosylated hemoglobin levels were significantly elevated in the diabetic mothers and their offspring as compared with controls (P < 0.001), and maternal and cord blood levels were highly correlated in the diabetic group (r = 0.61, P < 0.001). Cord serum C-peptide and glycosylated hemoglobin levels tended to be associated (r = 0.43, P < 0.10). Hypoglycemic infants of diabetic mothers (IDM) had significantly higher glycosylated hemoglobin levels (A443 nm/10 mg hemoglobin hemolysate) in cord blood (0.173 ± 0.009) than did IDM without hypoglycemia (0.153 ± 0.005, P < 0.01). Macrosomic and nonmacrosomic IDM, on the other hand, did not differ as to their glycosylated hemoglobin levels (0.162 ± 0.005 versus 0.161 ± 0.006, respectively). The occurrence of hypoglycemia was not associated with that of macrosomia (X2 = 0.24, P > 0.10). These data strongly suggest that neonatal hypoglycemia is the result of maternal hyperglycemia in pregnancy and consequent fetal hyperglycemia and hyperinsulinemia. However, maternal hyperglycemia in late pregnancy may not be a sufficient explanation for the development of macrosomia in IDM.

UR - http://www.scopus.com/inward/record.url?scp=0020329740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020329740&partnerID=8YFLogxK

M3 - Article

C2 - 6765511

AN - SCOPUS:0020329740

VL - 5

SP - 566

EP - 570

JO - Diabetes Care

JF - Diabetes Care

SN - 1935-5548

IS - 6

ER -